Adam Drapczuk
Net worth: 61 315 $ as of 30/06/2026
Net worth: 61 315 $ as of 30/06/2026
Adam E.
Drapczuk worked at West-Ward Pharmaceutical Corp.
from 2001 to 2011, serving as Finance Director from 2008 to 2011.
From 2011 to 2016, worked at Tris Pharma, Inc. as Finance Director & Controller.
In 2016, held the position of Chief Financial Officer & Vice President-Finance at Inpellis, Inc. Also in 2016, worked as Financial Controller at R-Pharm US LLC until 2020.
From 2021 to 2025, served as Chief Financial & Accounting Officer at NexGel, Inc., continuing in that role through 2026.
Education includes undergraduate studies at Susquehanna University.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
NEXGEL, INC. 1.33% | 03/06/2026 | 1,22,385 ( 1.33% ) | 61 315 $ | 30/06/2026 |
| Companies | Position | End |
|---|---|---|
| NEXGEL, INC. | Comptroller/Controller/Auditor | 27/04/2026 |
| NEXGEL, INC. | Director of Finance/CFO | 31/12/2025 |
R-Pharm US LLC
R-Pharm US LLC Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of medicines to treat cancer | Comptroller/Controller/Auditor | 01/04/2020 |
Inpellis, Inc.
Inpellis, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes transdermal prescription therapeutic products | Director of Finance/CFO | 01/04/2016 |
Tris Pharma, Inc.
Tris Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and delivers therapeutics for ADHD, pain, addiction & central nervous system disorders | Director of Finance/CFO | 01/02/2016 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 6 |
|---|---|
Susquehanna University
Susquehanna University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
West-Ward Pharmaceutical Corp.
West-Ward Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology Provides generic prescription medication services | Health Technology |
NexGel, Inc.
NexGel, Inc. Chemicals: SpecialtyProcess Industries Manufactures hydrogel compounds | Process Industries |
Tris Pharma, Inc.
Tris Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and delivers therapeutics for ADHD, pain, addiction & central nervous system disorders | Health Technology |
Inpellis, Inc.
Inpellis, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes transdermal prescription therapeutic products | Health Technology |
R-Pharm US LLC
R-Pharm US LLC Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of medicines to treat cancer | Health Technology |
Select your edition
All financial news and data tailored to specific country editions